University of North Carolina at Chapel Hill

Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial) (2025) Agarwal R, Green JB, Heerspink HJ, Mann JF, McGill JB, Mottl AK, Nangaku M, et al. Journal article Activation mapping in multi-center retrospective rat sensory-evoked functional MRI datasets using a unified pipeline (2025) Galteau ME, Broadwater M, Chen Y, Desrosiers-Gregoire G, Gil R, Käßer J, Kim E, et al. Journal article Combination effect of FInerenone and EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: Baseline clinical characteristics (2025) Agarwal R, Green JB, Heerspink HJ, Mann JF, McGill JB, Mottl AK, Rosenstock J, et al. Journal article Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial (2025) Marx N, Deanfield JE, Mann JF, Arechavaleta R, Bain SC, Bajaj HS, Bayer Tanggaard K, et al. Journal article A post-assembly conformational change makes the SARS-CoV-2 polymerase elongation-competent (2025) Klein M, Das A, Bera SC, Anderson TK, Kocincova D, Lee HW, Wang B, et al. Journal article Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes (2025) McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, Mann JF, et al. Journal article Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials (2025) Lee MM, Sattar N, Pop-Busui R, Deanfield J, Emerson SS, Inzucchi SE, Mann JF, et al. Journal article Clinical Trial: Safety and Efficacy of a Novel Oesophageal Delivery System for Topical Corticosteroids Versus Placebo in the Treatment of Eosinophilic Oesophagitis (2025) Lucendo AJ, Nantes-Castillejo Ó, Straumann A, Biedermann L, Bredenoord AJ, Guagnozzi D, Blas-Jhon L, et al. Journal article Heterozygous UBR5 variants result in a neurodevelopmental syndrome with developmental delay, autism, and intellectual disability (2025) Sabeh P, Dumas SA, Maios C, Daghar H, Korzeniowski M, Rousseau J, Lines M, et al. Journal article Consensus on acromegaly therapeutic outcomes: an update (2025) Melmed S, di Filippo L, Fleseriu M, Mercado M, Karavitaki N, Gurnell M, Salvatori R, et al. Journal article